About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: June 13, 2006
When Does Concern for Safety Impede Progress?
There is no question that since the post-COX-2 era has been one consumed with risk and not so much focus on benefit. But, as stated here many times, I am acutely aware of the benefit that drug and biologic interventions … Continue reading
Posted in Risk Management
Comments Off on When Does Concern for Safety Impede Progress?